Similarly, in a large institutional cohort [24] of 2,042 ECs analyzed by targeted massive parallel sequencing, CCNE1 amplification was detected in 22% of cases, most of which were serous and carcinosarcoma. This evidence concerns the gene CCNE1 and carcinosarcoma.